CoChat

Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta‐analysis of cohort studies

Open access
Shen, Zi‐Qi, Gao, Shan‐Yan, Li, Shawn Xiang, Zhang, Tie‐Ning, Liu, Cai‐Xia, Lv, Hai‐Chen, Zhang, Yuan, Gong, Ting‐Ting, Xu, Xin, Ji, Chao, Wu, Qi‐Jun, Li, Da · 2017 · British Journal of Clinical Pharmacology
Cited by 48

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Aim: To perform a meta‐analysis of available cohort studies on the association between sertraline use by pregnant women in the first trimester and the findings of congenital anomalies in infants. Methods: A comprehensive search of articles published from the index date up to 31 st December 2015 investigating the aforementioned associations was conducted on PubMed and Web of Science. Mesh headings used included the terms “serotonin reuptake inhibitor,” “sertraline,” “congenital anomalies” and “obstetrical outcome.” Results: Twelve cohort studies that involved 6 468 241 pregnant women were identified. We summarized odds ratios (ORs) and 95% confidence intervals (CIs) of congenital anomalies using the random‐effects model. Pregnant women who used sertraline in the first trimester had a statistically significant increased risk of infant cardiovascular‐related malformations (OR = 1.36; 95% CI = 1.06–1.74; I 2 = 64.4%; n = 12) as well as atrial and/or ventricular septal defects (OR = 1.36, 95% CI = 1.06–1.76; I 2 = 62.2%; n = 8). Additionally, positive but nonsignificant associations between sertraline use and congenital anomalies of the nervous system (OR = 1.39; 95% CI = 0.83–2.32; I 2 = 0%; n = 5), digestive system (OR = 1.23; 95% CI = 0.76–1.98; I 2 = 0%; n = 5), eye, ear, face and neck (OR = 1.08; 95% CI = 0.33–3.55; I 2 = 32.1%; n = 3), urogenital system (OR = 1.03; 95% CI = 0.73–1.46; I 2 = 0%; n = 5), and musculoskeletal system (OR = 0.97; 95% CI = 0.69–1.36; I 2 = 0%; n = 5) were observed. Conclusion: This meta‐analysis suggested that the use of sertraline use by pregnant women in the first trimester had an increased risk of cardiovascular‐related malformations as well as atrial and/or ventricular septal defects in infants. Meanwhile, nonsignificant associations between sertraline use and other congenital anomalies were found. More cohort studies are warranted to provide detailed results of other congenital anomalies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bcp.13161

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 48

Metadata

Authors
Shen, Z., Gao, S., Li, S. X., Zhang, T., Liu, C., Lv, H., Zhang, Y., Gong, T., Xu, X., Ji, C., Wu, Q., & Li, D.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2016-12-04
Volume
83
Issue
4
Pages
909-922
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W2533286547
Cited by
48
References
7
FWCI
5.14
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.